I think the CF Neg result was inline with the forecast in the last 4C which had costs of $4.5m.
We'll see the detail in the 4C but there was an extra $1m forecast for R&D, Operating and Advertising costs.
Having raised $3m at $0.16 and having a record sales quarter (up 10%) with increased costs I think the current sp is compelling value. Certainly better than my initial purchase after the placement.
Ann: CV1 - Strong B2B Growth Drives Record Revenue Quarter, page-6
Add KYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $47.69M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 274999 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 19256 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| KYP (ASX) Chart |
Day chart unavailable